EUVIMEDEUVIMED entdecken
Crossref

Melanin‐Like Nanomedicine Functions as a Novel RPE Ferroptosis Inhibitor to Ameliorate Retinal Degeneration and Visual Impairment in Dry Age‐Related Macular Degeneration

Keke Huang iD, Haoyue Deng, Shuang Wang, Fuxiao Zhang, Ge Huang, Lu Wang, Jianyu Liu, Xuli Zhao, Hui Ren, Guang Yang, Zhiqing Lin iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202401613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Keke Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, 610031, China. Hauptthemen laut MEDLINE: Ferroptosis, Retinal Pigment Epithelium, Oxidative Stress. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Chengdu Medical Scientific Research Project, Chengdu Science and Technology Bureau's technology innovation research and development project, Third People's Hospital of Chengdu Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferrous ion accumulation and lethal oxidative stress mediate irreversible retinal pigment epithelial (RPE) cell ferroptosis and subsequent photoreceptor degeneration, a potential key pathogenic factor in the onset of dry age‐related macular degeneration (dAMD), causing irreversible vision loss in the global elderly population. However, currently, no effective interventional treatment strategy exists in clinical practice. Herein, lesion site‐targeted melanin‐like nanoparticles, named ConA‐MelNPs, are designed as a novel ferroptosis inhibitor for retinal degenerative diseases. ConA‐MelNPs possessed chelating iron ion characteristics, alleviating severe mitochondrial damage caused by oxidative stress and protecting RPE cells from ferroptosis induced by sodium iodate (NaIO 3 ). In a preclinical dAMD mouse model, a single intravitreal injection of ConA‐MelNPs yielded significant responses in electroretinograms and visually‐driven optomotor responses in visually impaired mice, resisting the challenge posed by secondary NaIO 3 ‐induced injuries, with the long‐term sustainability of its therapeutic effect. Mechanistically, ConA‐MelNPs achieve a therapeutic effect by interrupting the detrimental cascade involving “RPE cell ferroptosis, lethal oxidative stress, and microglial proinflammatory activation,” affording the restoration of retinal homeostasis. The synthesized ConA‐MelNPs demonstrated good biosafety, with no detected ophthalmic or systemic side effects. Collectively, ConA‐MelNPs are proposed as a promising therapeutic option for atrophic retinal diseases such as dAMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisRetinal Pigment EpitheliumOxidative StressAnimalsMiceMelaninsIodatesHumansRetinal DegenerationNanoparticlesNanomedicineMice, Inbred C57BLMacular DegenerationDisease Models, AnimalElectroretinography

Stichwörter der Autor:innen

(Dry age‐related macular degenerationferroptosismelanin‐like nanomedicineoxidative stress)retinal pigmented epithelial

Substanzen

sodium iodateMelaninsIodates

Autor:innen und Institutionen

  • Department of Ophthalmology, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, 610031, China.
  • Department of Anaesthesiology, Southwest Hospital, The Third Military Medical University (Army Medical University), Chongqing, 400038, China.
  • Department of Ophthalmology, The Second People's Hospital of Chengdu, The Affiliated Hospital of Chengdu Medical College, Chengdu, 610031, China.
  • Department of Neurology, Medical Research Center, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, 610031, China.

ORCID-Profile: Keke Huang, Zhiqing Lin

Förderung

  • Chengdu Medical Scientific Research Project
  • Chengdu Science and Technology Bureau's technology innovation research and development project
  • Third People's Hospital of Chengdu Scientific Research Project
  • Sichuan Province Science and Technology Support Program

Zitieren

APA

Huang, K., Deng, H., Wang, S., Zhang, F., Huang, G., Wang, L., Liu, J., Zhao, X., Ren, H., Yang, G., & Lin, Z. (2024). Melanin‐Like Nanomedicine Functions as a Novel RPE Ferroptosis Inhibitor to Ameliorate Retinal Degeneration and Visual Impairment in Dry Age‐Related Macular Degeneration. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401613

Vancouver

Huang K, Deng H, Wang S, Zhang F, Huang G, Wang L, et al. Melanin‐Like Nanomedicine Functions as a Novel RPE Ferroptosis Inhibitor to Ameliorate Retinal Degeneration and Visual Impairment in Dry Age‐Related Macular Degeneration. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401613

BibTeX
@article{Huang2024,
  author = {Huang, Keke and Deng, Haoyue and Wang, Shuang and Zhang, Fuxiao and Huang, Ge and Wang, Lu and Liu, Jianyu and Zhao, Xuli and Ren, Hui and Yang, Guang and Lin, Zhiqing},
  title = {Melanin‐Like Nanomedicine Functions as a Novel RPE Ferroptosis Inhibitor to Ameliorate Retinal Degeneration and Visual Impairment in Dry Age‐Related Macular Degeneration},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202401613}
}
Kostenlos starten →